Label Image (Lbl500904883)
Valsartan And Hydrochlorothiazide
Product Images NDC 50090-4883
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-4883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Valsahctz Figur1)
This is a figure or chart depicting the probability of achieving a systolic blood pressure lower than 140 mmHg at week 8. The chart shows different medications and their dosages such as Valsartan and Hydrochlorothiazide tablets, as well as the baseline systolic blood pressure levels.*
Figure 2-3-4 (Valsahctz Figure2 3 4)
The text represents graphs and tables showing the probability of achieving certain blood pressure values at week 8 with the use of Valsartan, hydrochlorothiazide, and placebo. The graphs show the probability of achieving systolic blood pressure less than 130 mmHg and diastolic blood pressure less than 90 mmHg or 80 mmHg. It appears to be related to a medical study or clinical trial.*
Structure (Valsahctz Hctz)
Structure (Valsahctz Valsa)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
